Dr Elizabeth Swisher at the University of Washington Fred Hutch Cancer Center and her team at the Swisher Lab are currently conducting a research study titled "Clonal HemAtopoiesis iN CancEr Survivors (CHANCES)” and is seeking participants. This study will help better understand the connection between ovarian and other solid cancers, its treatments, and the development of serious secondary cancers such as AML ( acute myeloid leukemia) and MDS (myelodysplastic syndrome). This study is funded by the National Cancer Institute.
You are eligible to participate in the study if you live in the United States, have had recurrent ovarian, fallopian tube, or peritoneal carcinoma with any treatment history OR a history of ovarian cancer (on or off treatment) who has any of the following:
- Has been treated with more than 1 chemotherapy regimen (including if given for a different cancer type) or
- Has received at least 4 months of a PARP inhibitor or
- Has had low blood counts requiring referral to a hematologist for work up or
- Had known MDS, AML or clonal hematopoiesis
The duration of the study is 3 years. You will be asked to complete a short survey every 6 months and provide one or more blood samples ( at a lab of choice near you) over 3 years. You will receive a $50 gift card after completion of 6-month questionnaire.
Visit www.swisherlab.org/chances for more information about the study, eligibility, and the scientific team behind this research.
Please direct any questions to the Swisher Lab, via email (swisherlabrc@uw.edu) or phone (206-321-6648) .
Please share this info with others who may be interested in participating in this trial.
Dee and Christina
Co-founders #gyncsm
